(Q48318017)

10 February 2018

title

Concurrent chronic administration of a CCK(B) antagonist can decrease tolerance to the ataxic effects of ethanol. (English)

1 reference

10 February 2018

author name string

J Wilson

series ordinal

1

1 reference

10 February 2018

G N Woodruff

series ordinal

2

1 reference

10 February 2018

H J Little

series ordinal

3

1 reference

10 February 2018

publication date

1 January 1999

1 reference

10 February 2018

published in

Addiction Biology

1 reference

10 February 2018

volume

4

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

35-45

1 reference

10 February 2018

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13556219971821

The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI-988

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219971821

CI988, a selective antagonist of cholecystokininB receptors, prevents morphine tolerance in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219971821

CCK(B) antagonists protect against anxiety-related behaviour produced by ethanol withdrawal, measured using the elevated plus maze

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219971821

Anxiolytic effects of CCK-B antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219971821

'Anxiolytic' effect of CCK-antagonists on plus-maze behavior in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219971821

Evidence for an involvement of the brain cholecystokinin B receptor in anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219971821

The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219971821

The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219971821

Evaluation of the effects of PD 134308 (CI-988), A CCK-B antagonist, on the punished responding of squirrel monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219971821

Differential profile of the CCKB receptor antagonist CI-988 and diazepam in the four-plate test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219971821

The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219971821

Lack of effect of CCKB receptor antagonists in ethological and conditioned animal screens for anxiolytic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219971821

Action of chlormethiazole in a model of ethanol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219971821

Characteristics of 125I-Bolton-Hunter labelled cholecystokinin binding in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219971821

Brain CCK receptors: species differences in regional distribution and selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219971821

Heterogeneity of CCK-B receptors involved in animal models of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219971821

Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219971821

Morphine place conditioning is differentially affected by CCKA and CCKB receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219971821

PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219971821

Cholecystokinin and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13556219971821

21 January 2018

Identifiers

DOI

10.1080/13556219971821

1 reference

10 February 2018

1 reference

10 February 2018